|
Fritz Schroder of the Netherlands told
the European Cancer Conference that unnecessary tests are
being done and that has led to a lot of needless surgeries.
Schroder says it's unethical to apply
the Prostate Specific Antigen (PSA) test without telling patients
all the information about the test and the detection of prostate
cancer.
The PSA test looks for certain markers
in the blood - high levels suggest that the man may have prostate
cancer. It is generally done on men over 50.
The prostate gland lies just under the
bladder and is close to a number of tissues important in continence
and sexual function. It produces part of the fluid that carries
sperm.
Most are slow-growing
tumors
Schroder and other specialists point out
two-thirds of men with elevated PSA levels don't actually
have the disease. It could mean they have a simple infection
or inflammation of the prostate.
Some men with normal readings have turned
out to have cancer, so the test isn't accurate.
Statistics from the United States indicate
an increase in the detection of prostate cancer. However,
most of the cancers are slow-growing
tumors in elderly men who are unlikely to die from it.
In Canada, about seven out of every 10
men diagnosed with prostate cancer will die from other causes
such as heart disease, stroke
or old age.
Nevertheless, many have gone ahead with
radiotherapy or surgery to remove the prostate. Both carry
a high risk of leaving the patient impotent, incontinent,
or both.
According
to the data in the U.S.:
- 60 per cent were impotent 18 months
after surgery
- Eight per cent had complete urinary
incontinence
- 40 per cent had occasional urinary
problems
Schroder says the PSA tests are important
and useful but only when the patient is fully informed of
the facts.
He recommends doctors use a wait and see
approach if the patient tests positive. That means periodic
visits to see if the tumor has grown.
Canadian
Public Broadcasting October 25, 2001
|